1. |
Fasting during Ramadan: the effects of altered drug administration |
|
Inpharma Weekly,
Volume &NA;,
Issue 1459,
2004,
Page 2-2
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
2. |
Detecting, managing nonadherence to paediatric antiretroviral therapy |
|
Inpharma Weekly,
Volume &NA;,
Issue 1459,
2004,
Page 3-3
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
3. |
Linezolid good value in skin and soft tissue infections |
|
Inpharma Weekly,
Volume &NA;,
Issue 1459,
2004,
Page 4-4
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
4. |
A transdermal estradiol gel, Bio-E-Gel,*significantly improves hot flashes in menopausal women, |
|
Inpharma Weekly,
Volume &NA;,
Issue 1459,
2004,
Page 5-5
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
5. |
Canfosfamide combinations promising in ovarian cancer |
|
Inpharma Weekly,
Volume &NA;,
Issue 1459,
2004,
Page 6-6
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
6. |
Liraglutide looking good in type 2 diabetes |
|
Inpharma Weekly,
Volume &NA;,
Issue 1459,
2004,
Page 7-8
S Sullivan,,
Preview
|
|
摘要:
Liraglutide [NN 2211, NNC 901170] is effective as monotherapy and in combination with metformin in the treatment of type 2 diabetes mellitus, according to a study presented at the 40th Annual Meeting of the European Association for the Study of Diabetes (EASD) [Munich, Germany; September 2004]. Patients receiving liraglutide alone and in combination with metformin experienced significantly greater improvements in glycaemic control, compared with patients receiving metformin alone. Furthermore, patients in the liraglutide plus metformin group had better glycaemic control and greater reductions in bodyweight than glimepiride plus metformin recipients.
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
7. |
Short-term treatment with venlafaxine extended release (ER) is effective in patients with social phobia, |
|
Inpharma Weekly,
Volume &NA;,
Issue 1459,
2004,
Page 8-8
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
8. |
Docetaxel superior choice over mitoxantrone in prostate cancer |
|
Inpharma Weekly,
Volume &NA;,
Issue 1459,
2004,
Page 9-9
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
9. |
Tadalafil effective for erectile dysfunction after prostatectomy |
|
Inpharma Weekly,
Volume &NA;,
Issue 1459,
2004,
Page 10-10
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
10. |
Eprosartan protects against recurrent stroke |
|
Inpharma Weekly,
Volume &NA;,
Issue 1459,
2004,
Page 11-12
S Sullivan,,
Preview
|
|
摘要:
Eprosartan [Teveten] reduces the risk of secondary strokes in patients with hypertension, according to data presented at the 26th Annual Congress of the European Society of Cardiology (ESC) [Munich, Germany; August-September 2004]. The MOSES study showed that, although the two agents produced similar reductions in BP, eprosartan was more effective than nitrendipine in reducing the combined risk of mortality, cardiovascular events and cerebrovascular events in patients with a history of hypertension and a previous stroke. Furthermore, the number of recurrent cerebrovascular events was reduced in the eprosartan group by 25% more than the nitrendipine group.
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|